BMI MD GLP-1 / GIP Microdosing is a managed-approval CPA offer in the telehealth and weight management space. The campaign is available through Vexio for qualified partners who can drive compliant, high-intent traffic through approved promotional channels.
With a strong CPA payout and partner tracking, this offer may be a good fit for publishers, affiliates, email partners, native media buyers, and performance marketers with relevant health, wellness, weight management, or telehealth audiences.
Because this campaign is connected to GLP-1 / GIP-related weight management services, partners must follow all offer terms, approved traffic-source rules, and applicable advertising requirements. Promotional content should avoid exaggerated medical claims, guaranteed weight-loss results, prescription guarantees, misleading language, unauthorized brand bidding, or unapproved creatives. Vexio may review traffic sources, promotional methods, GEO fit, and compliance before approving access.
